Skip to main content

Table 3 Genomic and Transcriptomic Characterization of PDOX-LM models mimicking the donor liver metastases, Related to Fig. 5

From: A novel patient-derived organoids-based xenografts model for preclinical drug response testing in patients with colorectal liver metastases

Gene symbols

Log2FC

P

Patient #1 PDOX-LM vs. donor liver metastases

 CDX2,TP53,POLE, AXIN2, CDK2, CDK4, AKT1

0 to 2

NA

IGF2R, APC, MDM2, KRAS, EGFR, CTNNB1, CDK6, SMAD4, BRAF, ARID1A, MTOR, SMAD2, BCL3, PI3KCA, FBXW7, MAPKAP1, ERBB2, ERBB3, AKT2, TCFL2, NRAS

− 2 to 0

NA

Patient #2 PDOX-LM vs. donor liver metastases

 NRAS, KRAS ERBB3, EGFR, AXIN2, CDK4, BRAF, APC, FBXW7, TCF7L2, TP53, CDK2, MAP2K4, IGF2R

0 to 2

NA

IGF1R, MTOR, CDK6, AKT1, ARIDA1A, MDM2, AKT2, SMAD4, PI3KCA, ERBB2, CTNNB1

− 2 to 0

NA